Pharmaco - Press Releases

Date	Title	Company
16-Dec-2022	Dupixent® (dupilumab) approved by European Commission as the first and only targeted medicine indicated for prurigo nodularis	Sanofi
16-Dec-2022	Cutting-edge protein design project to join BioInnovation Institute’s Bio Studio program	BioInnovation Institute (BII)
16-Dec-2022	MinervaX announces 72M EUR financing to advance development of novel vaccine against Group B Streptococcus	MinervaX
16-Dec-2022	PAION AG issues statement on planned capital measure	PAION AG
16-Dec-2022	Heidelberg Pharma Signs Research and Exclusive Option Agreement with Binghamton University on Immunostimulatory Technology Platform	Heidelberg Pharma AG
16-Dec-2022	Körber Partner Program "PAS-X MSI Plug & Produce": The onoff AG receives the "Ready" certification	Körber
16-Dec-2022	Evotec achieves further progress in neuroscience collaboration with Bristol Myers Squibb	Evotec SE
15-Dec-2022	STRATEC TO PARTICIPATE IN THE 41ST ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE	STRATEC SE
15-Dec-2022	PM Society Awards - NEW CATEGORY	PM Society
15-Dec-2022	Calypso Biotech Announces First Patient with Eosinophilic Esophagitis Dosed in Anti-Interleukin-15 (IL-15) Monoclonal Antibody CALY-002 Phase 1a/b Trial, and Animal Proof of Concept Data in Atopic Dermatitis	B3C newswire
15-Dec-2022	T-CURX GmbH Announces the Appointment of Thomas (Tom) Loeser as CFO and the Attendance at the JPM 41st Annual Healthcare Conference 2023 in San Francisco	B3C newswire
15-Dec-2022	NICE issues positive recommendation to expand use of Ofev® (nintedanib) in idiopathic pulmonary fibrosis	Boehringer Ingelheim
15-Dec-2022	Qlucore participates in major EU project to prevent cardiovascular diseases	Qlucore
15-Dec-2022	UCB and Praxis Precision Medicines Announce Epilepsy Research Collaboration	UCB
15-Dec-2022	NoriZite™ Nasal Spray blocks infection with Omicron SARS-CoV-2 variant in cell culture	Sciad Newswire
15-Dec-2022	Axplora announces the grant of a Pharmaceutical Establishment License for its Le Mans site	Axplora
15-Dec-2022	ProtonDx Revs Up European Commercial Expansion with New Head of Sales	B3C newswire
15-Dec-2022	Cannovum AG share enters Xetra trading	Cannovum AG
15-Dec-2022	Defence Therapeutics Inc.: DEFENCE'S mRNA WITH ACCUMTM FOR CANCER VACCINES UPDATE	Defence Therapeutics Inc.
15-Dec-2022	Preventing Strokes and Heart Attacks Doesn't Have to Come with the Risk of Life-threatening Bleeding	Verseon International Corporation